Targeting Notch signaling cross-talk with estrogen receptor and ErbB-2 in breast cancer

Advances in Enzyme Regulation

Volumn 49, Issue 1, 2009, Pages 134-141

  Rizzo, Paola ^a   Osipo, Clodia ^a   Pannuti, Antonio ^a   Golde, Todd ^b   Osborne, Barbara ^c   Miele, Lucio ^a  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; NOTCH RECEPTOR;

ANIMAL; ARTICLE; BREAST TUMOR; FEMALE; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 66449120871     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2009.01.008     Document Type: Article

References (67)

1. Allenspach E.J., Maillard I., Aster J.C., and Pear W.S. Notch signaling in cancer. Cancer Biol Ther 1 (2002) 466-476
2. Bane A.L., Pinnaduwage D., Colby S., Bull S.B., O'Malley F.P., and Andrulis I.L. Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors. Breast Cancer Res Treat (2008)
3. Bender L.M., and Nahta R. Her2 cross talk and therapeutic resistance in breast cancer. Front Biosci 13 (2008) 3906-3912
4. Berman J.N., and Look A.T. Targeting transcription factors in acute leukemia in children. Curr Drug Targets 8 (2007) 727-737
5. Brou C., Logeat F., Gupta N., Bessia C., LeBail O., Doedens J.R., et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cells 5 (2000) 207-216
6. Chen Y., De Marco M.A., Graziani I., Gazdar A.F., Strack P.R., Miele L., et al. Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Cancer Res 67 (2007) 7954-7959
7. Cordle J., Johnson S., Tay J.Z., Roversi P., Wilkin M.B., de Madrid B.H., et al. A conserved face of the Jagged/Serrate DSL domain is involved in Notch trans-activation and cis-inhibition. Nat Struct Mol Biol 15 (2008) 849-857
8. Cordle J., Redfieldz C., Stacey M., van der Merwe P.A., Willis A.C., Champion B.R., et al. Localization of the delta-like-1-binding site in human Notch-1 and its modulation by calcium affinity. J Biol Chem 283 (2008) 11785-11793
9. Dallman M.J., Smith E., Benson R.A., and Lamb J.R. Notch: control of lymphocyte differentiation in the periphery. Curr Opin Immunol 17 (2005) 259-266
10. Dickson B.C., Mulligan A.M., Zhang H., Lockwood G., O'Malley F.P., Egan S.E., et al. High-level JAG1 mRNA and protein predict poor outcome in breast cancer. Mod Pathol 20 (2007) 685-693
11. Dreesen O., and Brivanlou A.H. Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev 3 (2007) 7-17
12. Fan X., Mikolaenko I., Elhassan I., Ni X., Wang Y., Ball D., et al. Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Res 64 (2004) 7787-7793
13. Farnie G., Brennan K., Clarke R.B., and Bundred N.J. Ductal carcinoma in situ (DCIS) mammosphere formation effect of epidermal growth factor (EGF) and notch signaling pathways on self-renewal capacity. Breast Cancer Res Treat Suppl. 1:S14 (2005) 94
14. Farnie G., and Clarke R.B. Mammary stem cells and breast cancer-role of Notch signalling. Stem Cell Rev 3 (2007) 169-175
15. Farnie G., Clarke R.B., Spence K., Pinnock N., Brennan K., Anderson N.G., et al. Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. J Natl Cancer Inst 99 (2007) 616-627
16. Gordon W.R., Vardar-Ulu D., Histen G., Sanchez-Irizarry C., Aster J.C., and Blacklow S.C. Structural basis for autoinhibition of Notch. Nat Struct Mol Biol 14 (2007) 295-300
17. Gupta-Rossi N., Six E., LeBail O., Logeat F., Chastagner P., Olry A., et al. Monoubiquitination and endocytosis direct gamma-secretase cleavage of activated Notch receptor. J Cell Biol 166 (2004) 73-83
18. Houde C., Li Y., Song L., Barton K., Zhang Q., Godwin J., et al. Over-expression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Blood 104 (2004) 3697-3704
19. Huang Y., Hoque M.O., Wu F., Trink B., Sidransky D., and Ratovitski E.A. Midkine induces epithelial-mesenchymal transition through Notch2/Jak2-Stat3 signaling in human keratinocytes. Cell Cycle 7 (2008) 1613-1622
20. Jundt F., Anagnostopoulos I., Forster R., Mathas S., Stein H., and Dorken B. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood 99 (2002) 3398-3403
21. Jundt F., Probsting K.S., Anagnostopoulos I., Muehlinghaus G., Chatterjee M., Mathas S., et al. Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. Blood 103 (2004) 3511-3515
22. Kamakura S., Oishi K., Yoshimatsu T., Nakafuku M., Masuyama N., and Gotoh Y. Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat Cell Biol 6 (2004) 547-554
23. Kanwar R., and Fortini M.E. The big brain aquaporin is required for endosome maturation and notch receptor trafficking. Cell 133 (2008) 852-863
24. Koch U., and Radtke F. Notch and cancer: a double-edged sword. Cell Mol Life Sci 64 (2007) 2746-2762
25. Kopan R., and Ilagan M.X. Gamma-secretase: proteasome of the membrane?. Nat Rev Mol Cell Biol 5 (2004) 499-504
26. Kukar T., and Golde T.E. Possible mechanisms of action of NSAIDs and related compounds that modulate gamma-secretase cleavage. Curr Top Med Chem 8 (2008) 47-53
27. Lee C.W., Raskett C.M., Prudovsky I., and Altieri D.C. Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. Cancer Res 68 (2008) 5273-5281
28. Li K., Li Y., Wu W., Gordon W.R., Chang D.W., Lu M., et al. Modulation of notch signaling by antibodies specific for the extracellular negative regulatory region of Notch3. J Biol Chem (2008)
29. McKenzie G.J., Khan M., Briend E., Stallwood Y., and Champion B.R. Notch: a unique therapeutic target for immunomodulation. Expert Opin Ther Targets 9 (2005) 395-410
30. Miele L. Notch signaling. Clin Cancer Res 12 (2006) 1074-1079
31. Miele L., Golde T., and Osborne B. Notch signaling in cancer. Curr Mol Med 6 (2006) 905-918
32. Minato Y., and Yasutomo K. Regulation of acquired immune system by notch signaling. Int J Hematol 82 (2005) 302-306
33. Minter L.M., Turley D.M., Das P., Shin H.M., Joshi I., Lawlor R.G., et al. Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nat Immunol 6 (2005) 680-688
34. Nam Y., Sliz P., Pear W.S., Aster J.C., and Blacklow S.C. Cooperative assembly of higher-order Notch complexes functions as a switch to induce transcription. Proc Natl Acad Sci USA 104 (2007) 2103-2108
35. Nam Y., Sliz P., Song L., Aster J.C., and Blacklow S.C. Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes. Cell 124 (2006) 973-983
36. Nickoloff B.J., Qin J.Z., Chaturvedi V., Denning M.F., Bonish B., and Miele L. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma. Cell Death Differ 9 (2002) 842-855
37. Noguera-Troise I., Daly C., Papadopoulos N.J., Coetzee S., Boland P., Gale N.W., et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Novartis Found Symp 283 (2007) 106-120
38. O'Neill C.F., Urs S., Cinelli C., Lincoln A., Nadeau R.J., Leon R., et al. Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth. Am J Pathol 171 (2007) 1023-1036
39. Okajima T., and Irvine K.D. Regulation of notch signaling by o-linked fucose. Cell 111 (2002) 893-904
40. Osipo C., Golde T.E., Osborne B.A., and Miele L.A. Off the beaten pathway: the complex cross talk between Notch and NF-kappaB. Lab Invest 88 (2008) 11-17
41. Osipo C., Patel P., Rizzo P., Clementz A.G., Hao L., Golde T.E., et al. ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor. Oncogene (2008)
42. Palomero T., Sulis M.L., Cortina M., Real P.J., Barnes K., Ciofani M., et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 13 (2007) 1203-1210
43. Parr C., Watkins G., and Jiang W.G. The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Int J Mol Med 14 (2004) 779-786
44. Pinnix C.C., and Herlyn M. The many faces of Notch signaling in skin-derived cells. Pigment Cell Res 20 (2007) 458-465
45. Pitsouli C., and Delidakis C. The interplay between DSL proteins and ubiquitin ligases in Notch signaling. Development 132 (2005) 4041-4050
46. Reedijk M., Odorcic S., Chang L., Zhang H., Miller N., McCready D.R., et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 65 (2005) 8530-8537
47. Ridgway J., Zhang G., Wu Y., Stawicki S., Liang W.C., Chanthery Y., et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444 (2006) 1083-1087
48. Rizzo P., Miao H., D'Souza G., Osipo C., Yun J., Zhao H., et al. Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res 68 (2008) 5226-5235
49. Rizzo P., Osipo C., Foreman K., Golde T., Osborne B., and Miele L. Rational targeting of Notch signaling in cancer. Oncogene 27 (2008) 5124-5131
50. Roy M., Pear W.S., and Aster J.C. The multifaceted role of Notch in cancer. Curr Opin Genet Dev 17 (2007) 52-59
51. Sahlgren C., and Lendahl U. Notch signaling and its integration with other signaling mechanisms. Regen Med 1 (2006) 195-205
52. Sansone P., Storci G., Giovannini C., Pandolfi S., Pianetti S., Taffurelli M., et al. p66Shc/Notch-3 interplay controls self-renewal and hypoxia survival in human stem/progenitor cells of the mammary gland expanded in vitro as mammospheres. Stem Cells 25 (2007) 807-815
53. Shepard H.M., Jin P., Slamon D.J., Pirot Z., and Maneval D.C. Herceptin. Handb Exp Pharmacol (2008) 183-219
54. Shih I., and Wang T.L. Notch signaling, gamma-secretase inhibitors, and cancer therapy. Cancer Res 67 (2007) 1879-1882
55. Song L.L., Peng Y., Yun J., Rizzo P., Chaturvedi V., Weijzen S., et al. Notch-1 associates with IKKalpha and regulates IKK activity in cervical cancer cells. Oncogene (2008)
56. Stylianou S., Clarke R.B., and Brennan K. Aberrant activation of notch signaling in human breast cancer. Cancer Res 66 (2006) 1517-1525
57. Thompson B.J., Buonamici S., Sulis M.L., Palomero T., Vilimas T., Basso G., et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med 204 (2007) 1825-1835
58. Thurston G., Noguera-Troise I., and Yancopoulos G.D. The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth. Nat Rev Cancer 7 (2007) 327-331
59. Tu L., Fang T.C., Artis D., Shestova O., Pross S.E., Maillard I., et al. Notch signaling is an important regulator of type 2 immunity. J Exp Med 202 (2005) 1037-1042
60. Ulhoa-Cintra A., Greenberg L., and Geyer C.E. The emerging role of lapatinib in HER2-positive breast cancer. Curr Oncol Rep 10 (2008) 10-17
61. Vilimas T., Mascarenhas J., Palomero T., Mandal M., Buonamici S., Meng F., et al. Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. Nat Med 13 (2007) 70-77
62. Wang Z., Banerjee S., Li Y., Rahman K.M., Zhang Y., and Sarkar F.H. Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res 66 (2006) 2778-2784
63. Wang Z., Zhang Y., Banerjee S., Li Y., and Sarkar F.H. Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells. Int J Cancer 118 (2006) 1930-1936
64. Weijzen S., Rizzo P., Braid M., Vaishnav R., Jonkheer S.M., Zlobin A., et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 8 (2002) 979-986
65. Yamaguchi N., Oyama T., Ito E., Satoh H., Azuma S., Hayashi M., et al. NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. Cancer Res 68 (2008) 1881-1888
66. Yan M., and Plowman G.D. Delta-like 4/Notch signaling and its therapeutic implications. Clin Cancer Res 13 (2007) 7243-7246
67. Zeng Q., Li S., Chepeha D.B., Giordano T.J., Li J., Zhang H., et al. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell 8 (2005) 13-23